4//SEC Filing
Kruse Bo 4
Accession 0001104659-23-005026
CIK 0001722964other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:34 PM ET
Size
7.8 KB
Accession
0001104659-23-005026
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Award
Common Stock
2023-01-17+11,700→ 192,777 total - Award
Employee Stock Option (right to buy)
2023-01-17+70,100→ 70,100 totalExercise: $4.70Exp: 2033-01-17→ Common Stock (70,100 underlying)
Footnotes (3)
- [F1]Represents 11,700 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2024, January 17, 2025 and January 17, 2026 subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001752940
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:34 PM ET
- Size
- 7.8 KB